30 Interstitial Lung Disease Clinical Trials in New York, NY (2026)

Q: How do I join a clinical trial in New York?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you.

Recruiting Interstitial Lung Disease Studies in New York

NCT06923371Recruiting

Moms and Babies Health and Well-being

The goal of this clinical trial is to see how giving direct cash support affects the health of pregnant women and their babies in the U.S. Many families, especially those with low incomes, face challe...

New York, NY1,250 participantsColumbia University

View Study Details

NCT06921993Recruiting

Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia

Pneumonia is a major cause of illness and death in children, with an annual incidence of about 3.3 per 1,000 in those under five years old, many requiring hospitalization. The diagnosis is challenging...

New York, NY659 participantsMeyer Children's Hospital IRCCS

View Study Details

NCT06572384Recruiting

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

Interstitial lung disease (ILD) is a lung condition resulting in inflammation and stiffening of the lung, often associated with connective tissue diseases (CTDs). ILD causes reduction in lung volume, ...

New York, NY440 participantsGlaxoSmithKline

View Study Details

NCT05976867Recruiting

Parent-focused Primary Prevention of Child Sexual Abuse: An Effectiveness-implementation Hybrid Trial

The goal of this clinical trial is to test the effectiveness of a parent-focused child sexual abuse prevention program (Smart Parents) delivered to parents enrolled in a parent education program (Pare...

New York, NY400 participantsNew York University

View Study Details

NCT04571658Recruiting

NEPTUNE Match Study

NEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicate patient-specific clinical trial matching with kidney patients and their physic...

New York, NY375 participantsUniversity of Michigan

View Study Details

NCT06951217Recruiting

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

This is an open-label extension study for participants who were previously enrolled in and completed an Avalyn Pharma Sponsored study with an inhaled antifibrotic, such as AP01. Eligible participants ...

New York, NY340 participantsAvalyn Pharma Inc.

View Study Details

NCT07009288Recruiting

A Study of Time-Restricted Eating in Childhood Cancer Survivors

This study will look at whether motivational sessions (including regular calls with a trained health coach) in combination with time-restricted eating (TRE) is an effective way to achieve weight loss ...

New York, NY300 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT04867395Recruiting

A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity

The overarching objective of this study is to make it easier for parents of children with medical complexity (CMC) to take care of their children after discharge home from the hospital and reduce the ...

New York, NY282 participantsNYU Langone Health

View Study Details

NCT04639830Recruiting

Electrophysiologic Sleep Phenotyping and Sleep-Dependent Neuro-maturation in Clinical and Healthy Pediatric Populations

Background: During the first few decades of life, the brain changes dramatically in shape and function. Sleep lets researchers measure these changes. Researchers want to create a database of sleep an...

New York, NY244 participantsNational Institute of Mental Health (NIMH)

View Study Details

NCT07489079Recruiting

PlayReadVIP in Family Child Care

This study uses a mixed-methods, single-group pretest-posttest design to evaluate (1) implementation outcomes (acceptability, adoption, fidelity) and (2) preliminary changes associated with delivery o...

New York, NY240 participantsNYU Langone Health

View Study Details

NCT06601933Recruiting

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

Effective, clinically meaningful treatments are lacking for patients with mild cognitive impairment (MCI), which is associated with increased risk of transition to dementia. Cognitive training represe...

New York, NY240 participantsColumbia University

View Study Details

NCT05935592Recruiting

Intervention INC: An Interactive Family-centered mHealth Tool to Reduce Obesity Risk in Urban Minority Preadolescents

Using a two-group randomized study design, this study aims to evaluate the effectiveness of the adapted family-centered mHealth tool on child BMI z-score (primary outcome), child dietary behaviors, an...

New York, NY200 participantsTufts University

View Study Details

NCT05655325Recruiting

Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity

The purpose of this study is to see if 6 months of home-based walking will improve memory, and brain structure and function, compared to health education in older adults that have chronic kidney disea...

New York, NY144 participantsColumbia University

View Study Details

NCT06924307Recruiting

Parent-Child EF Intervention

Koronis Biomedical Technologies Corporation (KBT) is developing a cognitive intervention to promote healthy development of Executive Function (EF) skills in young children by leveraging a smartphone-b...

New York, NY140 participantsKoronis Biomedical Technologies

View Study Details

NCT05571059Recruiting

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF....

New York, NY128 participantsCumberland Pharmaceuticals

View Study Details

NCT05016219Recruiting

Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients

Participants will randomly be placed into one of four groups and experience one of the four following conditions: (1) a placebo light that provides a 40 hertz (Hz) flicker (rhythmic light \[RL\]); (2)...

New York, NY120 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT07485725Recruiting

Digital Tools to Support Healthcare Decision Making

The goal for this project is to support the cognitive components of older adults' health-management activities through development of digital assistant technology tools tailored to three exemplar heal...

New York, NY120 participantsWeill Medical College of Cornell University

View Study Details

NCT03372317Recruiting

Tau PET in Imaging and Cognition: Healthy Adults From 55-90

The investigators aim to use the new PET radioligand, 18F-MK-6240, to detect tau pathology in cognitive healthy and mild cognitive impairment (MCI) elders. The investigators will then examine the inte...

New York, NY105 participantsYaakov Stern

View Study Details

NCT07321587Recruiting

Activity Tracking, Care Partner Co-participation, Text Reminders, Instructional Education, Video-Guided Physical Rehabilitation, and Exercise

This is a multi-methods two-arm, crossover, analyst-blinded randomized controlled trial with embedded qualitative interviews, enrolling 50 dyads (older adult-care partner). Participants will receive t...

New York, NY100 participantsNYU Langone Health

View Study Details

NCT07201922Recruiting

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

This study is open to people aged 40 years or older who have at least 1 family member with pulmonary fibrosis. Pulmonary fibrosis is a condition where lung tissue becomes scarred, making it harder to ...

New York, NY80 participantsBoehringer Ingelheim

View Study Details

NCT07036523Recruiting

A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

This study is open to adults who are at least 40 years old and have idiopathic pulmonary fibrosis (IPF). People can participate in the study if they have a forced vital capacity (FVC) greater than or ...

New York, NY71 participantsBoehringer Ingelheim

View Study Details

NCT05879367Recruiting

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

The purpose of this study is to establish the recommended phase 2 dose of eflornithine in combination with temozolomide in patients whose glioblastoma or astrocytoma is newly diagnosed, and to evaluat...

New York, NY66 participantsOrbus Therapeutics, Inc.

View Study Details

NCT06102941Recruiting

Cognitive Control Targets for the Treatment of Obsessive Compulsive Disorder in Young Children

This study aims to examine the effects of a game-like program called cognitive control training (CT) for children with obsessive compulsive disorder (OCD). Children enrolled in this study will receive...

New York, NY60 participantsColumbia University

View Study Details

NCT05191706Recruiting

Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

A Phase 3/4, Prospective, Randomized, Active Treatment-Controlled, Parallel-Design, Multicenter Study to Evaluate the Safety of DEXYCUfor the Treatment of Inflammation Following Ocular Surgery for Chi...

New York, NY60 participantsEyePoint Pharmaceuticals, Inc.

View Study Details

NCT06825403Recruiting

Olfactory Training in Mild Cognitive Impairment

Sense of smell tends to decline in individuals with early Alzheimer's disease, typically earlier than when other senses and thinking abilities begin to decline. Memory for new odors is particularly di...

New York, NY30 participantsJeffrey Motter

View Study Details

NCT07553338Recruiting

Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease

The present study will administer the drug leronlimab to 20 participants who are above 50 years old with Alzheimer's disease (AD) or mild cognitive impairment (MCI) due to AD. While leronlimab is cons...

New York, NY20 participantsWeill Medical College of Cornell University

View Study Details

NCT05606341Recruiting

Innate Immunity Stimulation Via TLR9 in Early AD

This single-center, double-blind, placebo-controlled study will recruit in total 39 participants with either Mild Cognitive Impairment due to Alzheimer's disease (MCI) or Mild Alzheimer's disease deme...

New York, NY18 participantsNYU Langone Health

View Study Details

NCT02602769Recruiting

Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

Rapid onset Obesity, Hypoventilation, Hypothalamic dysfunction and Autonomic Dysregulation (ROHHAD) is a syndrome named in 2007. The hallmark of the syndrome is the rapid onset obesity and dysregulati...

New York, NY12 participantsColumbia University

View Study Details

NCT06781840Recruiting

Promoting Health Through Play Program: Improving Parent and Child Outcomes

This project aims to assess the feasibility of an intervention program consisting of parent online group sessions in addition to guided individual play session between parent, child, and occupational ...

New York, NY10 participantsYeshiva University

View Study Details

NCT07142499Recruiting

Memory Support System for Older Chinese Americans With Mild Cognitive Impairment

The Memory Support System (MSS) from the Healthy Action to Benefit Independence \& Thinking® (HABIT) Program is an evidence-based, non-pharmacological intervention for mild cognitive impairment (MCI)....

New York, NY7 participantsIcahn School of Medicine at Mount Sinai

View Study Details

About Interstitial Lung Disease Clinical Trials in New York

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 30 interstitial lung disease clinical trials recruiting participants in New York, NY. These studies are seeking a combined 6,261 participants. Research is being sponsored by Columbia University, Meyer Children's Hospital IRCCS, GlaxoSmithKline and 17 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in New York — FAQ

Are there interstitial lung disease clinical trials in New York?

Yes, there are 30 interstitial lung disease clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 30 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated July 13, 2026 from ClinicalTrials.gov